Genome Sequence Variability Predicts Drug Precautions and Withdrawals from the Market.

Main|Search|PHGKB




Last Posted: Sep 29, 2017

---

• Genome Sequence Variability Predicts Drug Precautions and Withdrawals from the Market.  
  Lee Kye Hwa et al. PloS one (9) e0162135
• The Challenges of Implementing Pharmacogenomic Testing in the Clinic.  
  Moyer Ann M et al. Expert review of pharmacoeconomics & outcomes research 2017 Sep
• Effect of Genotype-Guided Warfarin Dosing on Clinical Events and Anticoagulation Control Among Patients Undergoing Hip or Knee Arthroplasty  
  BF Gage et al, JAMA 26, Sep 2017
• Pharmacogenomic Testing and Warfarin  
  JD Emery et al, JAMA Sep 26, 2017
• Cost-Utility Study of Warfarin Genotyping in the VACHS Affiliated Anticoagulation Clinic of Puerto Rico.  
  Martes-Martinez Carlos et al. Puerto Rico health sciences journal 2017 Sep 36(3) 165-172
• Genetic Test, Risk Prediction, and Counseling.  
  Wang Maggie Haitian et al. Advances in experimental medicine and biology 2017 100521-46
• Pharmacogenomics Implementation at the National Institutes of Health Clinical Center.  
  Sissung Tristan M et al. Journal of clinical pharmacology 2017 Oct 57 Suppl 10S67-S77
• Population Pharmacokinetics and Pharmacogenetics Analysis of Rilpivirine in HIV-1-Infected Individuals.  
  Aouri Manel et al. Antimicrobial agents and chemotherapy 2017 Jan 61(1)
• Germline Genetic Variants with Implications for Disease Risk and Therapeutic Outcomes.  
  Pasternak Amy L et al. Physiological genomics 2017 Sep physiolgenomics.00035.2017
• Review of the Reported Measures of Clinical Validity and Clinical Utility as Arguments for the Implementation of Pharmacogenetic Testing: A Case Study of Statin-Induced Muscle Toxicity.  
  Jansen Marleen E et al. Frontiers in pharmacology 2017 8555
• Role of pharmacogenomics in antiepileptic drug therapy: current status and future perspectives.  
  Gambardella Antonio et al. Current pharmaceutical design 2017 Sep
• Systematic review: genetic biomarkers associated with anti-TNF treatment response in inflammatory bowel diseases.  
  Bek S et al. Alimentary pharmacology & therapeutics 2016 Sep 44(6) 554-67
• Pharmacogenetics and precision medicine: Is inflammation a covert threat to effective genotype-based therapy?  
  Shah Rashmi R et al. Therapeutic advances in drug safety 2017 Sep 8(9) 267-272
• Pharmacogenomic Variability of Oral Baclofen Clearance and Clinical Response in Children with Cerebral Palsy.  
  McLaughlin Matthew J et al. PM & R : the journal of injury, function, and rehabilitation 2017 Aug
• The impact of Fc gamma receptor IIa and IIIa gene polymorphisms on the therapeutic response of rituximab in Egyptian adult immune thrombocytopenic purpura.  
  Ellithy Hend N et al. Hematology (Amsterdam, Netherlands) 2017 Aug 1-6
• Updating the landscape of direct-to-consumer pharmacogenomic testing.  
  Filipski Kelly K et al. Pharmacogenomics and personalized medicine 2017 10229-232

more